---
$id: https://graph.org.ai/products/commodity/51102875
$type: Product
source: UNSPSC
code: "51102875"
title: "Ambroxol/amoxicllin"
class: "51102800"
classTitle: "Combination anti-infectives"
family: "51100000"
familyTitle: "Amebicides and trichomonacides and antiprotozoals"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Ambroxol/amoxicllin

**UNSPSC Code**: 51102875
**Class**: [Combination anti-infectives](Combination anti-infectives.mdx)
**Family**: [Amebicides and trichomonacides and antiprotozoals](../Amebicides and trichomonacides and antiprotozoals.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a combination drug composed of two constituents: a mucolytic and an aminopenicillin, as more fully appears. The first constituent, ambroxol (51162702) is an expectorant and amino-alcohol that bears the molecular formula C13H18BR2N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 200168S0CL, chemically known as 4-[(2-Amino-3,5-dibromobenzyl)amino]cyclohexanol but more generally known as ambroxol [EU/ESIS 242-500-3]; ambroxol comes in forms acefyllinate [0HM1E174TN], base, and hydrochloride [CC995ZMV90]. European Medicines Agency schedules AMBROXOL in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05397MIG (base), SUB12842MIG (acefyllinate), and SUB00427MIG (hydrochloride). The term AMBROXOL is an International Non-Proprietary Name or INN. World Health Organization schedules ambroxol in its Anatomical Therapeutic Chemical (ATC) Classification (R05CB06) and in its WHO Drug Dictionary. AMBROXOL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule ambroxol under HS 29221980 and SITC 51461. US Census, for industry purposes, classifies ambroxol under NAICS 325199. The second constituent in this preparation is amoxicillin {51281702}, a penicillin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 804826J2HU. Amoxicillin comes in forms anhydrous, hydrate, sodium, and trihydrate {51281710, 51281711, 51281712, 51281713}. European Medicines Agency schedules Amoxicillin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05481MIG. Amoxicillin generally arises in the molecular formula C16H19N3O5S. The term AMOXICILLIN is a European Pharmacopoeia designation. AMOXICILLIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule amoxicillin under HS 29411010 and SITC 54131. As of Q4 2014, AMOXICILLIN remains the US FDA Preferred Term for this commodity. Amoxicillin bears US NLM identifiers UMLS ID C0002645 and NCI Concept Code C237. Practitioners typically use this combination drug in treatment of chronic bronchitis and similar maladies.

